The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Privia Health Group Inc shares valued at $236,469 were sold by Mehrotra Parth on Mar 10 ’25. At $24.53 per share, Mehrotra Parth sold 9,640 shares. The insider’s holdings dropped to 489,189 shares worth approximately $11.44 million following the completion of this transaction.
Also, Mehrotra Parth sold 9,294 shares, netting a total of over 221,941 in proceeds. Following the sale of shares at $23.88 each, the insider now holds 479,895 shares.
Before that, Mountcastle David had sold 2,979 shares from its account. In a trade valued at $73,075, the EVP & Chief Financial Officer traded Privia Health Group Inc shares for $24.53 each. Upon closing the transaction, the insider’s holdings decreased to 2,979 shares, worth approximately $4.4 million.
As published in their initiating research note from Needham on January 10, 2025, Privia Health Group Inc [PRVA] has been a Buy and the price target has been revised to $25. Analysts at Macquarie started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid December. As of October 11, 2024, KeyBanc Capital Markets has initiated its “an Overweight” rating for PRVA. Earlier on May 30, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for PRVA stock.
Analyzing PRVA Stock Performance
During the last five days, there has been a drop of approximately -7.44%. Over the course of the year, Privia Health Group Inc shares have jumped approximately 19.59%. Shares of the company reached a 52-week high of $26.04 on 02/27/25 and a 52-week low of $19.47 on 01/02/25. A 50-day SMA is recorded $23.09, while a 200-day SMA reached $20.08.
Support And Resistance Levels for Privia Health Group Inc (PRVA)
According to the 24-hour chart, there is a support level at 23.10, which, if violated, would cause prices to drop to 22.83. In the upper region, resistance lies at 23.88. The next price resistance is at 24.39. RSI (Relative Strength Index) is 42.86 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.92, which suggests the price will decrease in the coming days. Percent R is at 98.15%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
